ArticleMolecular medicine (Cambridge, Mass.)2026
Fibroblast-associated protection against hypoxia and carboplatin-induced cytotoxicity during coculture with osteosarcoma.
Article in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteosarcoma progression and treatment resistance are strongly influenced by the tumour microenvironment. One of the key players in tumour microenvironments is cancer-associated fibroblast. Much of the conventional cancer-associated fibroblast-centred research paradigm focuses on the secretory and matrix-remodelling aspects of fibroblasts. However, less is known on how fibroblasts influence osteosarcoma cell behaviour, particular under stress.
methodsIn a proof-of-concept study, human dermal fibroblasts and osteosarcoma cells were studied using direct coculture and size-restricted transwell systems. Fluorescent labelling, confocal microscopy, live-cell imaging, and single-cell tracking were used to assess intercellular transfer, migratory behaviour, proliferation, and survival under chemotherapy and hypoxic challenge.
resultsOsteosarcoma cells acquired fibroblast-derived, mitochondria cargo-enriched material in both direct and indirect coculture systems, with transfer of material enhanced under carboplatin and hypoxic stress. Notably, fibroblast coculture increased osteosarcoma cell migration and promoted survival under stress but did not substantially increase basal proliferation.
conclusionsThese findings suggest that fibroblast-to-cancer cell transfer of mitochondria-enriched cargo is accelerated during stress conditions with the concomitant observation of proportional osteosarcoma protection to degree of fibroblast cargo transfer. Further research should examine stress-amplified transfer during tumour adaptation, chemoresistance, and metastatic behaviour, potentially highlighting stromal intercellular communication as an important aspect of osteosarcoma biology.
Indexed as
Identifiers
42823661What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.